Nicholas A. Saccomano

Director & President and CEO

Director & President and CEO at OnKure Therapeutics, Inc., filing insider transactions between 2026-03-23 and 2026-06-22.

Total Purchases

—

0 transactions

Total Sales

$736

2 transactions

Companies Traded

2 total filings

Active Since

2026-03-23

Last: 2026-06-22

Companies

OnKure Therapeutics, Inc.

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-06-22	OKUR	Sale	86	$4.40	$378	11.2K	SEC ↗
2026-03-23	OKUR	Sale	86	$4.16	$357	7,333	SEC ↗